MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2024.07.019

Медицинская библиотека · American heart journal · 2024

A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trial.

Stähli Barbara E, Linke Axel, Westermann Dirk, Van Mieghem Nicolas M, Leistner David M, Massberg Steffen, Alber Hannes, Mügge Andreas, Musumeci Giuseppe, Kesterke Rahel, Schneider Steffen, Kastrati Adnan, Ford Ian, Ruschitzka Frank, Kasel Markus A, TAVI PCI Investigators

Протокол клинического исследованияСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

About half of patients with severe aortic stenosis present with concomitant coronary artery disease. The optimal timing of percutaneous coronary intervention (PCI) and transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis and concomitant coronary artery disease remains unknown.

STUDY

DESIGN

The TAVI PCI trial is a prospective, international, multicenter, randomized, 2-arm, open-label study planning to enroll a total of 986 patients. It is designed to investigate whether the strategy "angiography-guided complete revascularization after (within 1-45 days) TAVI" is noninferior to the strategy "angiography-guided complete revascularization before (within 1-45 days) TAVI" using the Edwards SAPIEN 3 or 3 Ultra Transcatheter Heart Valve in patients with severe aortic stenosis and concomitant coronary artery disease. Patients are randomized in a 1:1 ratio to one of the 2 treatment strategies. The primary end point is a composite of all-cause death, nonfatal myocardial infarction, ischemia-driven revascularization, rehospitalization (valve- or procedure-related including heart failure), or life-threatening/disabling or major bleeding at 1 year.

CONCLUSIONS

The TAVI PCI trial tests the hypothesis that the strategy "PCI after TAVI" is noninferior to the strategy "PCI before TAVI" in patients with severe aortic stenosis and concomitant coronary artery disease.

Для цитирования: Stähli Barbara E, Linke Axel, Westermann Dirk, Van Mieghem Nicolas M, Leistner David M, Massberg Steffen, Alber Hannes, Mügge Andreas, Musumeci Giuseppe, Kesterke Rahel, Schneider Steffen, Kastrati Adnan, Ford Ian, Ruschitzka Frank, Kasel Markus A, TAVI PCI Investigators. A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trial.. American heart journal. 2024. DOI: 10.1016/j.ahj.2024.07.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.